Page 1511 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 84 Malignant Lymphomas in Childhood 1342.e1

REFERENCES trials LMT96, EORTC 58881, and EORTC 58951. Br J Haematol
152:441, 2011.
1. Mariotto AB, Rowland JH, Yabroff KR, et al: Long-term survivors of 23. Muljono A, Graf NS, Arbuckle S: Primary cutaneous lymphoblastic
childhood cancers in the United States. Cancer Epidemiol Biomarkers lymphoma in children: series of eight cases with review of the literature.
Prev 18:1033, 2009. Pathology 41:223, 2009.
2. Jaglowski SM, Linden E, Termuhlen AM, et al: Lymphoma in adoles- 24. Salzburg J, Burkhardt B, Zimmermann M, et al: Prevalence, clinical
cents and young adults. Semin Oncol 36:381, 2009. pattern, and outcome of CNS involvement in childhood and adolescent
3. Gurney JG, Severson RK, Davis S, et al: Incidence of cancer in children non-Hodgkin’s lymphoma differ by non-Hodgkin’s lymphoma subtype:
in the United States. Cancer 75:2186, 1995. a Berlin-Frankfurt-Münster Group report. J Clin Oncol 25:3915, 2007.
4. Murphy SB, Fairclough DL, Hutchison RE, et al: Non-Hodgkin’s 25. Murphy SB: Classification, staging and end results of treatment of
lymphomas of childhood: an analysis of the histology, staging, and childhood non-Hodgkin’s lymphomas: dissimilarities from lymphomas
response to treatment of 338 cases at a single institution. J Clin Oncol in adults. Semin Oncol 7:332, 1980.
7:186–193, 1989. 25a. Rosolen A, Perkins SL, Pinkerton CR, et al: Revised International
5. Filipovich AH, Heinitz KJ, Robison LL, et al: The Immunodeficiency Pediatric Non-Hodgkin Lymphoma Staging System. J Clin Oncol
Cancer Registry: a research resource. Am J Pediatr Hematol Oncol 9:183, 33(18):2112–2118, 2015.
1987. 26. Reiter A, Schrappe M, Ludwig WD, et al: Intensive ALL-type therapy
6. Sandlund JT, Fonseca T, Leimig T, et al: Predominance and charac- without local radiotherapy provides a 90% event-free survival for
teristics of Burkitt lymphoma among children with non-Hodgkin children with T-cell lymphoblastic lymphoma: a BFM group report.
lymphoma in northeastern Brazil. Leukemia 11:743, 1997. Blood 95:416, 2000.
7. Magrath IT: African Burkitt’s lymphoma: history, biology, clinical 27. Coustan-Smith E, Sandlund JT, Perkins SL, et al: Minimal dissemi-
features, and treatment. Am J Pediatr Hematol Oncol 13:222, 1991. nated disease in childhood T-cell lymphoblastic lymphoma: a report
8. Shad A, Magrath I: Malignant non-Hodgkin’s lymphomas in children. from the Children’s Oncology Group. J Clin Oncol 27:3533, 2009.
In Pizzo PA, Poplack DG, editors: Principles and practice of pediatric 28. Burkhardt B, Oschlies I, Klapper W, et al: Non-Hodgkin’s lymphoma
oncology, ed 3, Philadelphia, 1997, Lippincott-Raven, p 545. in adolescents: experiences in 378 adolescent NHL patients treated
9. Harris NL, Jaffe ES, Stein H, et al: A revised European-American according to pediatric NHL-BFM protocols. Leukemia 25:153, 2011.
classification of lymphoid neoplasms: a proposal from the International 29. Marks DI, Paietta EM, Moorman AV, et al: T-cell acute lymphoblastic
Lymphoma Study Group. Blood 84:1361, 1994. leukemia in adults: clinical features, immunophenotype, cytogenetics,
10. Campo E, Swerdlow SH, Harris NL, et al: The 2008 WHO clas- and outcome from the large randomized prospective trial (UKALL XII/
sification of lymphoid neoplasms and beyond: evolving concepts and ECOG 2993). Blood 114:5136, 2009.
practical applications. Blood 117:5019, 2011. 30. Hoelzer D, Gokbuget N, Digel W, et al: Outcome of adult patients
11. Burkhardt B, Zimmermann M, Oschlies I, et al: The impact of age with T-lymphoblastic lymphoma treated according to protocols for
and gender on biology, clinical features and treatment outcome of acute lymphoblastic leukemia. Blood 99:4379, 2002.
non-Hodgkin lymphoma in childhood and adolescence. Br J Haematol 31. Patte C, Kalifa C, Flamant F, et al: Results of the LMT81 protocol, a
131:39, 2005. modified LSA2L2 protocol with high dose methotrexate, on 84 children
12. Reiter A, Schrappe M, Parwaresch R, et al: Non-Hodgkin’s lymphomas with non-B-cell (lymphoblastic) lymphoma. Med Pediatr Oncol 20:105,
of childhood and adolescence: results of a treatment stratified for 1992.
biologic subtypes and stage—a report of the Berlin-Frankfurt-Münster 32. Tubergen DG, Krailo MD, Meadows AT, et al: Comparison of treat-
Group. J Clin Oncol 13:359, 1995. ment regimens for pediatric lymphoblastic non-Hodgkin’s lymphoma:
13. Weiss LM, Bindl JM, Picozzi VJ, et al: Lymphoblastic lymphoma: an a Childrens Cancer Group study. J Clin Oncol 13:1368, 1995.
immunophenotype study of 26 cases with comparison to T cell acute 33. Amylon MD, Shuster J, Pullen J, et al: Intensive high-dose asparaginase
lymphoblastic leukemia. Blood 67:474, 1986. consolidation improves survival for pediatric patients with T cell acute
14. Percy C, O’Conor G, Ries LG, et al: Non-Hodgkin’s lymphomas: lymphoblastic leukemia and advanced stage lymphoblastic lymphoma:
application of the International Classification of Diseases for Oncology a Pediatric Oncology Group study. Leukemia 13:335, 1999.
(ICD-O) to the Working Formulation. Cancer 54:1435, 1984. 34. Burkhardt B, Woessmann W, Zimmermann M, et al: Impact of cranial
15. Oschlies I, Burkhardt B, Chassagne-Clement C, et al: Diagnosis and radiotherapy on central nervous system prophylaxis in children and
immunophenotype of 188 pediatric lymphoblastic lymphomas treated adolescents with central nervous system-negative stage III or IV lym-
within a randomized prospective trial: experiences and preliminary phoblastic lymphoma. J Clin Oncol 24:491, 2006.
recommendations from the European childhood lymphoma pathology 35. Uyttebroeck A, Suciu S, Laureys G, et al: Treatment of childhood
panel. Am J Surg Pathol 35:836, 2011. T-cell lymphoblastic lymphoma according to the strategy for acute
16. Bernard A, Boumsell L, Reinherz EL, et al: Cell surface characterization lymphoblastic leukaemia, without radiotherapy: long term results of
of malignant T cells from lymphoblastic lymphoma using monoclonal the EORTC CLG 58881 trial. Eur J Cancer 44:840, 2008.
antibodies: evidence for phenotypic differences between malignant T 36. Abromowitch M, Termuhlen A, Chang M, et al: High-dose methotrex-
cells from patients with acute lymphoblastic leukemia and lymphoblas- ate and early intensification of therapy do not improve 3 year EFS in
tic lymphoma. Blood 57:1105, 1981. children and adolescents with disseminated lymphoblastic lymphoma:
17. Ritz J, Nadler LM, Bhan AK, et al: Expression of common acute results of the randomized arms of COG A5971 [abstract]. Blood
lymphoblastic leukemia antigen (CALLA) by lymphomas of B-cell and 112:3610, 2008.
T-cell lineage. Blood 58:648, 1981. 37. Pillon M, Piglione M, Garaventa A, et al: Long-term results of AIEOP
18. Bonn BR, Rohde M, Zimmermann M, et al: Incidence and prognostic LNH-92 protocol for the treatment of pediatric lymphoblastic lym-
relevance of genetic variations in T-cell lymphoblastic lymphoma in phoma: a report of the Italian Association of Pediatric Hematology and
childhood and adolescence. Blood 121:3153, 2013. Oncology. Pediatr Blood Cancer 53:953, 2009.
19. Callens C, Baleydier F, Lengline E, et al: Clinical impact of NOTCH1 38. Sandlund JT, Pui CH, Zhou Y, et al: Effective treatment of advanced-
and/or FBXW7 mutations, FLASH deletion, and TCR status in pediat- stage childhood lymphoblastic lymphoma without prophylactic cranial
ric T-cell lymphoblastic lymphoma. J Clin Oncol 30:1966, 2012. irradiation: results of St Jude NHL13 study. Leukemia 23:1127,
20. Bernard A, Murphy SB, Melvin S, et al: Non-T, non-B lymphomas are 2009.
rare in childhood and associated with cutaneous tumor. Blood 59:549, 39. Asselin BL, Devidas M, Wang C, et al: Effectiveness of high-dose
1982. methotrexate in T-cell lymphoblastic leukemia and advanced-stage
21. Link MP, Roper M, Dorfman RF, et al: Cutaneous lymphoblastic lymphoblastic lymphoma: a randomized study by the Children’s Oncol-
lymphoma with pre-B markers. Blood 61:838, 1983. ogy Group (POG 9404). Blood 118:874, 2011.
22. Ducassou S, Ferlay C, Bergeron C, et al: Clinical presentation, evolu- 40. Termuhlen AM, Smith LM, Perkins SL, et al: Outcome of newly diag-
tion, and prognosis of precursor B-cell lymphoblastic lymphoma in nosed children and adolescents with localized lymphoblastic lymphoma